about
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well...
Read More
2.12
0.01
(0.47%)
843.5K
XNAS Volume
XNAS 28 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Annexon Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..